# Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty

> **NCT00548288** · PHASE1 · UNKNOWN · sponsor: **General and Teaching Hospital Celje** · enrollment: 40 (estimated)

## Conditions studied

- Arthroplasty
- Mineral Density

## Interventions

- **DRUG:** pamidronate

## Key facts

- **NCT ID:** NCT00548288
- **Lead sponsor:** General and Teaching Hospital Celje
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2007-11
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00548288

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00548288, "Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00548288. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*